enGene Therapeutics Inc. (ENGN): 8-K filed Jun 10, 2026

Form type

8-K

Filing date

Jun 10, 2026

Accession number

0001193125-26-265830

Filer

enGene Therapeutics Inc. (CIK 1980845)